A Case of Fulminant Hepatitis after Administration of Abiraterone Acetate
A 77-year-old man with castration-resistant prostate cancer (CRPC) received abiraterone acetate in October 2014. He visited our outpatient clinic because of general malaise and anorexia 27 days after starting abiraterone acetate. The lab test showed hepatic dysfunction (aspartate transaminase, AST 4...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 63(2017), 11 vom: 25. Nov., Seite 479-482
|
|---|
| 1. Verfasser: |
Yumiba, Satoru
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Komori, Kazuhiko,
Iwanishi, Toshichika,
Koida, Youhei,
Kobayashi, Masao,
Ono, Yutaka |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | Japanese |
|---|
| Veröffentlicht: |
2017
|
|---|
| Zugriff auf das übergeordnete Werk: | Hinyokika kiyo. Acta urologica Japonica
|
|---|
| Schlagworte: | Case Reports
Journal Article
Abiraterone acetate
CRPC
Antineoplastic Agents
Prostate-Specific Antigen
EC 3.4.21.77
Abiraterone Acetate
EM5OCB9YJ6 |
|---|